DHF receives $200,000 grant from Novo Nordisk

Diabetes Hands Foundation (DHF) has received a grant of US$200,000 from Novo Nordisk to support programs aimed at bringing together people touched by diabetes for positive change so that nobody living with this disease ever feels alone. “We are truly grateful for Novo Nordisk’s deep commitment of resources and the positive impact this grant will have on every one of our programs in 2015,” commented Manny Hernandez, Co-founder and President of Diabetes Hands Foundation.

“The generosity of this grant reflects Novo’s commitment to change diabetes by supporting efforts aimed at improving the daily lives of people touched by diabetes.” Diabetes Hands Foundation runs two online communities for people touched by diabetes: TuDiabetes (in English) and EsTuDiabetes (in Spanish), with 66,000 registered members and nearly 3 million annual visitors from around the world. A portion of this grant will help cover some of the costs of migrating these two communities to a new software platform that will support future growth beyond 2015. The Big Blue Test is the second program run by DHF and is aimed at demonstrating the positive impact that even a little bit of exercise can have on blood sugars. Each exercise session logged triggers matching grants to organizations serving people with diabetes living in need. Over the past five years over 100,000 exercise sessions have generated nearly $300,000 in grants.

With this grant, Novo Nordisk becomes the first partner to get behind the Big Blue Test in 2015. Diabetes Advocates is the third program run by DHF, with a mission to connect advocates dedicated to improving the lives of people living with diabetes in order to accelerate and amplify their efforts. This grant will help expand the reach and impact by supporting part of the costs associated with building an online diabetes advocacy hub.

“We are delighted to partner with the Diabetes Hands Foundation on these critical programs that serve those affected by diabetes,” said Diana Blankman, Novo Nordisk’s Senior Director, US Corporate Giving & Social Impact.  “Through DHF’s social networks and advocacy efforts they are reaching, and more importantly, connecting people with programs and services to support their diabetes journey.”

# # #

About Novo Nordisk Headquartered in Denmark, Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy, and hormone replacement therapy.

Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries. For more information, visit novonordisk-us.com or follow our news in the U.S. on Twitter: @NovoNordiskUS. About Diabetes Hands Foundation (DHF) Diabetes Hands Foundation (www.DiabetesHandsFoundation.org) brings together people touched by diabetes for positive change to make sure that nobody living with this condition ever feels alone.

Diabetes can be a very isolating disease. We provide opportunities for people with diabetes and their loved ones to connect and have an open dialog about their experiences with this chronic condition. Instead of looking at the disease, DHF seeks to understand, connect, and energize the millions of people living with this condition. DHF hosts two active online communities for people touched by diabetes: TuDiabetes.org (in English) and EsTuDiabetes.org (in Spanish); the Big Blue Test, a program for empowerment through exercise; and Diabetes Advocates, a consortium of champions for people touched by diabetes.